Multidisciplinary analysis of cancer-related fatigue at the time of diagnosis: preliminary results of the BIOCARE FActory cohort

Archive ouverte

Leclercq, A. | Chatrenet, A. | Bourgeois, H. | Cojocarasu, O. | Mathie, C. | Martin, Tristan | Rahmani, A. | Morel, B.

Edité par CCSD ; Springer Verlag (Germany) -

International audience. Purpose. Cancer-related fatigue (CRF) is a common side effect of cancer and cancer treatment that significantly impairs thequality of life and can persist for years after treatment completion. Although fatigue is often associated with cancer treatment,it is also a result of the disease itself, even before intervention. CRF at the time of diagnosis may affect treatmenttiming or completion and is a consistent predictor of post-treatment fatigue at any time. The mechanisms underlying CRFare multidimensional and not well understood, particularly at the time of diagnosis.Methods. Sixty-five breast cancer patients at the time of diagnosis were included. The participants completed self-assessmentquestionnaires about CRF, sleep disturbances, and emotional symptoms and wore an accelerometer to assess levelsof spontaneous physical activity and sleep quality. During the experimental session, the participants underwent cognitive,neuromuscular, and exercise metabolism evaluations.Results. Using augmented backward elimination regression, this study found that emotional symptoms and perceived sleepdisturbances were the strongest predictors of CRF (adjusted r2 = 0.51). Neuromuscular fatigability and sleep disturbancewere also associated with physical dimensions, whereas cognitive performance was associated with cognitive dimensions.Conclusion. At the time of diagnosis, emotional and cognitive dimensions are over-represented compared to the generalpopulation, and specific subdimensions have specific predictors that support the idea of distinct mechanisms. EvaluatingCRF subdimensions and their potential mechanisms at the time of diagnosis would be particularly relevant for identifyinghigh-risk patients and offering them appropriate interventions.Trial registration This study was registered at ClinicalTrials.gov (NCT04391543) in May, 2020.

Consulter en ligne

Suggestions

Du même auteur

Building a biopsychosocial model of cancer-related fatigue: the BIOCARE FActory cohort study protocol

Archive ouverte | Chartogne, Martin | CCSD

International audience. Background : Cancer-related fatigue (CRF) is the most common side effect of cancer and cancer treatment. CRF prevalence is up to 50% in breast cancer patients and can continue several years a...

Comparison of neuromuscular fatigability amplitude and etiologies between fatigued and non-fatigued cancer patients

Archive ouverte | Chartogne, M. | CCSD

International audience. Purpose: Cancer-related fatigue (CRF) is the most reported side effect of cancer and its treatments. Mechanisms of CRF are multidimensional, including neuromuscular alterations leading to dec...

Correlation between baseline 18F-FDG PET/CT features and pathological complete response after neoadjuvant chemotherapy in early triple negative breast cancer

Archive ouverte | Bouron, C. | CCSD

International audience. Aim of the studyTo evaluate correlation between metabolic and textural parameters on baseline 18F-FDG PET/CT and pathological response after neoadjuvant chemotherapy in non-metastatic triple ...

Chargement des enrichissements...